Efficacy (Preliminary) and Safety of Artificial Salivary Containing Cumin and Ginger Extract in Healthy Volunteer
1 other identifier
interventional
112
1 country
1
Brief Summary
This study is a preliminary clinical study about safety of artificial salivary containing cumin and ginger extract in 21 healthy volunteers. After the preliminary clinical study, safety of artificial salivary containing cumin and ginger extract in 112 healthy volunteers. The volunteers will be divided into 2 groups which are artificial salivary containing cumin and ginger extract group and commercial artificial salivary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2021
CompletedFirst Posted
Study publicly available on registry
August 10, 2021
CompletedStudy Start
First participant enrolled
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedFebruary 7, 2024
February 1, 2024
5 months
August 3, 2021
February 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Salivary acid and base value
Salivary acid and base value (scale 0 (acid) to 14 (base)) using strip test
6 days
Secondary Outcomes (3)
Mucositis
6 days
Adverse event
6 days
Dry mouth status
6 days
Study Arms (2)
artificial salivary containing cumin and ginger extract
EXPERIMENTALThe artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the artificial salivary containing cumin and ginger extract will be stopped for 7-10 days. After that, the artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 3 days.
Commercial artificial salivary
ACTIVE COMPARATORThe commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the commercial artificial salivary will be stopped for 7-10 days. After that, the commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 3 days.
Interventions
The artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the artificial salivary containing cumin and ginger extract will be stopped for 7-10 days. After that, the artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 3 days.
The commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the commercial artificial salivary will be stopped for 7-10 days. After that, the commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 3 days.
Eligibility Criteria
You may qualify if:
- Age more than 18 years
- World Health Organization Oral Mucositis Grading Scale =0
- No using artificial salivary or activated salivary medicine more than 2 weeks
- No cumin, ginger, xylitol, glycerin allergy
- Have a willingness to participate in the study
You may not qualify if:
- Uncontrolled disease
- Dry mouth
- Salivary gland disease, inflammation, or sialolith
- Pregnancy or lactation
- During participated in other study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
Bangkok, 10310, Thailand
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 3, 2021
First Posted
August 10, 2021
Study Start
February 15, 2024
Primary Completion
June 30, 2024
Study Completion
July 31, 2024
Last Updated
February 7, 2024
Record last verified: 2024-02